1．Tashiro H, Sauer T, Shum T, Parikh K, Mamonkin M, Omer B, Rouce R, Lulla P, Rooney C, Gottschalk S, Brenner MK.
Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1., Mol Ther., 25（9）：2202-2213, 2017
2．Tashiro H, Brenner MK.
Immunotherapy against cancer-related viruses. , Cell Res. , 27（1）：59-73, 2017
3．Tanaka M, Tashiro H, Omer B, Lapteva N, Ando J, Ngo M, Mehta B, Dotti G, Kinchington PR, Leen AM, Rossig C, Rooney CM.
Vaccination targeting native receptors to enhance the function and proliferation of chimeric antigen receptor (CAR)-modified T cells. , Clin Cancer Res., 23（14）：3499-3509, 2017
4．Schmueck-Henneresse M, Omer B, Shum T, Tashiro H, Mamonkin M, Lapteva N, Sharma S, Rollins L, Dotti G, Reinke P, Volk HD, Rooney CM. Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells., J Immunol., 199（1）：348-362, 2017
5．Heczey A, Louis CU, Savoldo B, Dakhova O, Durett A, Grilley B, Liu H, Wu MF, Mei Z, Gee A, Mehta B, Zhang H, Mahmood N, Tashiro H, Heslop HE, Dotti G, Rooney CM, Brenner MK. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017 Jun 8; 25(9):2214-2224
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma., Mol Ther., 25（9）：2214-2224, 2017
6．Kimiko Nogi, Haruko Tashiro, Kazuo Kawasugi, Mayumi Matsuzawa, Takeshi Osawa, Ryohei Toyooka, Taiji Furukawa, Naoki Shirafuji. 2(2): doi.org/10.16966/2572-9578.116
Aggressive NK Cell Leukemia with Hemophagocytic Lymphohistiocytosis: A Case Report, Journal of Clinical and Laboratory Medicine, 2（2）：doi.org/10.16966/2572-9578.116 , 2017
7．Kimura S, Fujita H, Akiyama N, et al.
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group, Supportive Care in Cancer, 25（11）：3515-3521, 2017
ページ上部に戻る
